Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Pricing
Rankings
For Publishers
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Pricing
Rankings
For Publishers
Log In
Start Free Trial
Vera Bril
Sign up to set email alerts
1,233
Publications
24,141
Citation Statements Received
28,334
Citation Statements Given
How they've been cited
30,009
901
23,105
135
How they cite others
30,670
1,216
26,905
213
Affiliations
University of Toronto
,
University Health Network
Publications
Order By: Most citations
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
Pop‐Busui
1
,
Boulton
2
,
Feldman
3
et al.
2016
2,760
34
2,601
6
Get article
Add to collection
Cite
Diabetic neuropathy
Feldman
1
,
Callaghan
2
,
Pop‐Busui
3
et al.
2019
Nat Rev Dis Primers
1,896
30
1,507
2
Get article
Add to collection
Cite
Diabetic Neuropathies
Boulton
1
,
VINIK
2
,
Arezzo
3
et al.
2005
1,912
20
1,364
3
Get article
Add to collection
Cite
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
Hughes
1
,
Donofrio
2
,
Bril
3
et al.
2008
The Lancet Neurology
693
31
738
4
3
Get article
Add to collection
Cite
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Howard
1
,
Utsugisawa
2
,
Benatar
3
et al.
2017
The Lancet Neurology
881
38
694
6
5
Get article
Add to collection
Cite
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
Howard
1
,
Bril
2
,
Vu
3
et al.
2021
The Lancet Neurology
778
45
594
3
3
Get article
Add to collection
Cite
Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity
Dyck
1
,
Albers
2
,
Andersen
3
et al.
2011
Diabetes Metabolism Res
Abstract
Show
507
6
375
1
Get article
Add to collection
Cite
Validation of the Toronto Clinical Scoring System for Diabetic Polyneuropathy
Bril
1
,
Perkins
2
2002
Abstract
Show
477
10
351
1
Get article
Add to collection
Cite
1
2